Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R: Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7: 219-231. 10.1038/nrendo.2010.217.
Article
CAS
PubMed
Google Scholar
Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome. Lancet. 2007, 370: 685-697. 10.1016/S0140-6736(07)61345-2.
Article
CAS
PubMed
Google Scholar
Rizzo M, Berneis K, Spinas G, Rini GB, Carmina E: Long-term consequences of polycystic ovary syndrome on cardiovascular risk. Fertil Steril. 2009, 91: 1563-1567. 10.1016/j.fertnstert.2008.09.070.
Article
PubMed
Google Scholar
Moran LJ, Misso ML, Wild RA, Norman RJ: Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010, 16: 347-363. 10.1093/humupd/dmq001.
Article
CAS
PubMed
Google Scholar
Hughes C, Elgasim M, Layfield R, Atiomo W: Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review. Hum Reprod. 2006, 21: 2766-2775. 10.1093/humrep/del222.
Article
CAS
PubMed
Google Scholar
Diamanti-Kandarakis E, Piperi C, Spina J, Argyrakopoulou G, Papanastasiou L, Bergiele A, Panidis D: Polycystic ovary syndrome: the influence of environmental and genetic factors. Hormones (Athens). 2006, 5: 17-34.
Article
Google Scholar
Diamanti-Kandarakis E: Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Exp Rev Mol Med. 2008, 10: e3.
Article
Google Scholar
Mukherjee S, Maitra A: Molecular & genetic factors contributing to insulin resistance in polycystic ovary syndrome. Indian J Med Res. 2010, 131: 743-760.
CAS
PubMed
Google Scholar
Azziz R: Polycystic ovary syndrome, insulin resistance, and molecular defects of insulin signaling. J Clin Endocrinol Metab. 2002, 87: 4085-4087. 10.1210/jc.2002-021131.
Article
CAS
PubMed
Google Scholar
Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C: Cardiovascular risk in women with polycystic ovary syndrome. J Cardiovasc Med (Hagerstown). 2008, 9: 987-992. 10.2459/JCM.0b013e32830b58d4.
Article
Google Scholar
Wang ET, Calderon-Margalit R, Cedars MI, Daviglus ML, Merkin SS, Schreiner PJ, Sternfeld B, Wellons M, Schwartz SM, Lewis CE, Williams OD, Siscovick DS, Bibbins-Domingo K: Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011, 117: 6-13. 10.1097/AOG.0b013e31820209bb.
Article
PubMed
PubMed Central
Google Scholar
Franks S: Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006, 91: 786-789.
Article
CAS
PubMed
Google Scholar
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81: 19-25.
Google Scholar
Wishart DS: Metabolomics: the principles and potential applications to transplantation. Am J Transplant. 2005, 5: 2814-2820. 10.1111/j.1600-6143.2005.01119.x.
Article
CAS
PubMed
Google Scholar
Lenz EM, Wilson ID: Analytical strategies in metabonomics. J Proteome Res. 2007, 6: 443-458. 10.1021/pr0605217.
Article
CAS
PubMed
Google Scholar
Wu Q, Zhang Q, Sun B, Yan X, Tang Y, Qiao X, Chen Q, Yu S, Liang F: 1H NMR-based metabonomic study on the metabolic changes in the plasma of patients with functional dyspepsia and the effect of acupuncture. J Pharm Biomed Anal. 2010, 51: 698-704. 10.1016/j.jpba.2009.09.042.
Article
CAS
PubMed
Google Scholar
Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L: Metabolic profiling analysis of a d-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res. 2007, 6: 2161-2167. 10.1021/pr0606326.
Article
CAS
PubMed
Google Scholar
Yang Y, Qiao J, Li R, Li MZ: Is interleukin-18 associated with polycystic ovary syndrome?. Reprod Biol Endocrinol. 2011, 9: 7-10.1186/1477-7827-9-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sun L, Hu W, Liu Q, Hao Q, Mao S, Sun B, Zhang Q, Qiao J, Yan X: Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res. 2012, 11: 2937-2946. 10.1021/pr3000317.
Article
CAS
PubMed
Google Scholar
Wild RA, Rizzo M, Clifton S, Carmina E: Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011, 95: 1073-1079. 10.1016/j.fertnstert.2010.12.027.
Article
CAS
PubMed
Google Scholar
Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N: Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf). 2001, 54: 447-453. 10.1046/j.1365-2265.2001.01228.x.
Article
CAS
Google Scholar
Marei WF, Wathes DC, Fouladi-Nashta AA: Impact of linoleic acid on bovine oocyte maturation and embryo development. Reproduction. 2010, 139: 979-988. 10.1530/REP-09-0503.
Article
CAS
PubMed
Google Scholar
Toborek M, Lee YW, Garrido R, Kaiser S, Hennig B: Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells. Am J Clin Nutr. 2002, 75: 119-125.
CAS
PubMed
Google Scholar
Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, Haqq AM, Shah SH, Arlotto M, Slentz CA, Rochon J, Gallup D, Ilkayeva O, Wenner BR, Yancy WJ, Eisenson H, Musante G, Surwit RS, Millington DS, Butler MD, Svetkey LP: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009, 9: 311-326. 10.1016/j.cmet.2009.02.002.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang TJ, Larson MG, Vasan RS, Cheng S, Rhee EP, McCabe E, Lewis GD, Fox CS, Jacques PF, Fernandez C, O'Donnell CJ, Carr SA, Mootha VK, Flore JC, Souza A, Melander O, Clish CB, Gerszten RE: Metabolite profiles and the risk of developing diabetes. Nat Med. 2011, 17: 448-453. 10.1038/nm.2307.
Article
PubMed
PubMed Central
Google Scholar
Wurtz P, Tiainen M, Makinen VP, Kangas AJ, Soininen P, Saltevo J, Keinanen-Kiukaanniemi S, Mantyselka P, Lehtimaki T, Laakso M, Jula A, Kahonen M, Vanhala M, Ala-Korpela M: Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care. 2012, 35: 1749-1756. 10.2337/dc11-1838.
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia-Macedo R, Sanchez-Munoz F, Almanza-Perez JC, Duran-Reyes G, Alarcon-Aguilar F, Cruz M: Glycine increases mRNA adiponectin and diminishes pro-inflammatory adipokines expression in 3T3-L1 cells. Eur J Pharmacol. 2008, 587: 317-321. 10.1016/j.ejphar.2008.03.051.
Article
CAS
PubMed
Google Scholar
Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC, Papadimas I, Panidis D: Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009, 15: 297-307. 10.1093/humupd/dmp006.
Article
CAS
PubMed
Google Scholar
Li F, Yin Y, Tan B, Kong X, Wu G: Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids. 2011, 41: 1185-1193. 10.1007/s00726-011-0983-2.
Article
CAS
PubMed
Google Scholar
Macotela Y, Emanuelli B, Bang AM, Espinoza DO, Boucher J, Beebe K, Gall W, Kahn CR: Dietary leucine--an environmental modifier of insulin resistance acting on multiple levels of metabolism. PLoS One. 2011, 6: e21187-10.1371/journal.pone.0021187.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chand AL, Legge M: Amino acid transport system L activity in developing mouse ovarian follicles. Hum Reprod. 2011, 26: 3102-3108. 10.1093/humrep/der298.
Article
CAS
PubMed
Google Scholar
Guastella E, Longo RA, Carmina E: Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010, 94: 2197-2201. 10.1016/j.fertnstert.2010.02.014.
Article
CAS
PubMed
Google Scholar
Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D: Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study. Hum Reprod. 2012, 27: 541-549. 10.1093/humrep/der418.
Article
CAS
PubMed
Google Scholar
Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA: Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol. 2009, 161: 583-589. 10.1530/EJE-09-0398.
Article
CAS
PubMed
Google Scholar
Escobar-Morreale HF, Samino S, Insenser M, Vinaixa M, Luque-Ramirez M, Lasuncion MA, Correig X: Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem. 2012, 58: 999-1009. 10.1373/clinchem.2011.176396.
Article
CAS
PubMed
Google Scholar
Chen MJ, Chiu HM, Chen CL, Yang WS, Yang YS, Ho HN: Hyperandrogenemia is independently associated with elevated alanine aminotransferase activity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2010, 95: 3332-3341. 10.1210/jc.2009-2698.
Article
CAS
PubMed
Google Scholar
Diao FY, Xu M, Hu Y, Li J, Xu Z, Lin M, Wang L, Zhou Y, Zhou Z, Liu J, Sha J: The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol. 2004, 33: 59-72. 10.1677/jme.0.0330059.
Article
CAS
PubMed
Google Scholar